LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

33.96 0.15

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

33.32

Max

34.1

Põhinäitajad
By Trading Economics
Sissetulek	11M 51M
Müük	39M 239M
P/E Sektori keskmine	10.038 105.69
Aktsiakasum	1.08
Kasumimarginaal	21.242
Töötajad	268
EBITDA	12M 71M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+35.17% upside

Turustatistika
By TradingEconomics
Turukapital	145M 1.8B
Eelmine avamishind	33.81
Eelmine sulgemishind	33.96

Uudiste sentiment

By Acuity

34%

66%

104 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. nov 2025, 19:25 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18. nov 2025, 18:09 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18. nov 2025, 17:39 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18. nov 2025, 16:25 UTC

Suurimad hinnamuutused turgudel

Diginex Rises on Deal With Digital Asset Platform Evident

18. nov 2025, 23:56 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18. nov 2025, 23:39 UTC

Market Talk

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18. nov 2025, 22:59 UTC

Market Talk

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18. nov 2025, 22:08 UTC

Market Talk

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18. nov 2025, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18. nov 2025, 22:03 UTC

Tulu

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. nov 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

18. nov 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. nov 2025, 21:15 UTC

Market Talk

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18. nov 2025, 20:46 UTC

Market Talk

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18. nov 2025, 20:13 UTC

Market Talk

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18. nov 2025, 19:48 UTC

Market Talk

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18. nov 2025, 18:29 UTC

Tulu

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. nov 2025, 18:18 UTC

Market Talk

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18. nov 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

18. nov 2025, 17:19 UTC

Market Talk

Tulu

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18. nov 2025, 17:06 UTC

Tulu

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18. nov 2025, 16:06 UTC

Omandamised, ülevõtmised, äriostud

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18. nov 2025, 15:59 UTC

Tulu

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18. nov 2025, 15:35 UTC

Omandamised, ülevõtmised, äriostud

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18. nov 2025, 15:35 UTC

Omandamised, ülevõtmised, äriostud

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

35.17% tõus

12 kuu keskmine prognoos

Keskmine 46 USD 35.17%

Kõrge 62 USD

Madal 32 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

Osta

Hoia

Müü

Põhineb 10 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

104 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.